← FDA Drug Approvals (Drugs@FDA)
LEVOMILNACIPRAN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2023-03-20
Drug application
- FDA Application #
ANDA210771- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LEVOMILNACIPRAN HYDROCHLORIDE
- Generic name
- Levomilnacipran Hydrochloride
- Active ingredients
- LEVOMILNACIPRAN HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PRINSTON INC
- First approval
- 2023-03-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown